Terms: = Sarcomas AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1010 results:
1. Investigating the molecular mechanism of Mori Cortex against osteosarcoma by bioinformatics analysis and in vitro experimental.
Wang Y; Wang L; Xie D; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38261. PubMed ID: 38758844
[TBL] [Abstract] [Full Text] [Related]
2. Uncovering the WWTR1::NCOA2 Gene fusion in low-grade myoepithelial-rich neoplasm with HMGA2 expression: A case report.
Alsugair Z; Pissaloux D; Descotes F; Tirode F; Lopez J; Perrot J; Lapierre A; Fieux M; Philouze P; Champagnac A; Onea M; Benzerdjeb N
Genes Chromosomes Cancer; 2024 May; 63(5):e23244. PubMed ID: 38747338
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
4. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/erk pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract] [Full Text] [Related]
5. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/erk and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
6. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.
Grit JL; McGee LE; Tovar EA; Essenburg CJ; Wolfrum E; Beddows I; Williams K; Sheridan RTC; Schipper JL; Adams M; Arumugam M; Vander Woude T; Gurunathan S; Field JM; Wulfkuhle J; Petricoin EF; Graveel CR; Steensma MR
Oncogene; 2024 May; 43(19):1411-1430. PubMed ID: 38480916
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract] [Full Text] [Related]
8. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of the RAF/MEK/erk Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
10. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating p38/JNK Signaling Pathway.
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P
Int J Nanomedicine; 2024; 19():1097-1108. PubMed ID: 38327597
[TBL] [Abstract] [Full Text] [Related]
11. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
Akade E; Jalilian S
Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
[TBL] [Abstract] [Full Text] [Related]
12. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through erk/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract] [Full Text] [Related]
13. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
14. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract] [Full Text] [Related]
15. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models.
Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
[TBL] [Abstract] [Full Text] [Related]
16. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
[TBL] [Abstract] [Full Text] [Related]
17. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
18. Acantholytic squamous cell carcinoma mimicking epithelioid angiosarcoma: A diagnostic challenge by cytology.
Taweevisit M; Sutthiruangwong P; Thorner PS
Diagn Cytopathol; 2024 Mar; 52(3):E76-E79. PubMed ID: 38069674
[TBL] [Abstract] [Full Text] [Related]
19. Network pharmacology-based research on the effect of Scutellaria baicalensis on osteosarcoma and the underlying mechanism.
Zhang L; Tian Y; Wang J; Deng S; Fan H
Medicine (Baltimore); 2023 Nov; 102(46):e35957. PubMed ID: 37986331
[TBL] [Abstract] [Full Text] [Related]
20. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway.
Wu X; Cao Y; Xiao H; Feng J; Lin J
J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
[TBL] [Abstract] [Full Text] [Related]
[Next]
